Fabentech<\/a>\u00a0vient d\u2019obtenir l\u2019autorisation de mise sur le march\u00e9 fran\u00e7ais du premier antidote mondial \u00e0 la ricine, a annonc\u00e9 l\u2019entreprise fond\u00e9e en 2009 ce lundi. Une innovation qui attire d\u00e9j\u00e0 les curiosit\u00e9s du monde entier. Car la ricine, une substance naturelle parmi \u00ables plus toxiques au monde\u00bb, repr\u00e9sente \u00abun risque bioterroriste av\u00e9r\u00e9\u00bb, souligne la start-up. Si bien que la petite soci\u00e9t\u00e9 bio pharmaceutique de 50 employ\u00e9s a d\u00e9j\u00e0 sign\u00e9 des contrats avec plusieurs pays europ\u00e9ens, pour un montant de 20 millions d\u2019euros.<\/p>\n\u00abRicimed r\u00e9pond \u00e0 un besoin m\u00e9dical jusqu\u2019ici non satisfait dans la prise en charge d\u2019intoxications graves et potentiellement mortelles \u00e0 cette toxine, vante Fabentech. En compl\u00e9ment des soins de support, dans les situations graves et qui n\u00e9cessitent une administration imm\u00e9diate, Ricimed constitue une nouvelle modalit\u00e9 de prise en charge de l\u2019intoxication aigu\u00eb \u00e0 la ricine\u00bb. Il s\u2019agit\u2026<\/p>\n
\n Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s. Il vous reste 77% \u00e0 d\u00e9couvrir.\n <\/p>\n
![\"Le]()
<\/p>\n
Le Figaro c\u00e9l\u00e8bre ses 200 ans<\/p>\n
Offre anniversaire : 2\u20ac\/mois pendant 200 semaines<\/p>\n
\n D\u00e9j\u00e0 abonn\u00e9\u00a0?
\n Connectez-vous
\n <\/a>\n <\/p>\n","protected":false},"excerpt":{"rendered":"Soutenue par le minist\u00e8re des Arm\u00e9es, l\u2019entreprise lyonnaise Fabentech vient d\u2019obtenir l\u2019autorisation de mise sur le march\u00e9 fran\u00e7ais…\n","protected":false},"author":2,"featured_media":660165,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1889],"tags":[1111,11,1813,2430,48630,1777,674,1011,27,2428,12,25,1254],"class_list":{"0":"post-660164","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-lyon","8":"tag-actu","9":"tag-actualites","10":"tag-armee","11":"tag-auvergne-rhone-alpes","12":"tag-biotechnologie","13":"tag-eu","14":"tag-europe","15":"tag-fr","16":"tag-france","17":"tag-lyon","18":"tag-news","19":"tag-republique-francaise","20":"tag-terrorisme"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115886696848881644","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/660164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=660164"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/660164\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/660165"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=660164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=660164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=660164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}